Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending February 2016. The report serves as a notification of transactions involving Persons Discharging Managerial Responsibilities (PDMR) in accordance with DTR 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of insider trading activity rather than a financial performance report.
Material Changes
No material changes to financial performance or operations are reported in this filing. The only reported activity is the acquisition of shares by a PDMR.
Management Commentary and Unusual Items
The filing details a specific transaction where Mrs. V A Whyte, a PDMR, acquired 776 Ordinary Shares on February 12, 2016. These shares were acquired through the exercise of options granted on December 1, 2012, under GSK's ShareSave Plan at an option price of £11.59 per share. The Company and the individual were advised of this transaction on February 15, 2016.
Investor Verification Checklist
- Verify the total number of shares acquired by Mrs. V A Whyte (776 shares).
- Confirm the exercise price of the options (£11.59 per share).
- Check the grant date of the exercised options (December 1, 2012).
- Review the ShareSave Plan terms to understand the vesting and exercise conditions.